🇺🇸 FDA
Patent

US 6803375

Non-peptide inhibition of T-lymphocyte activation and therapies related thereto

expired A61KA61K31/065A61K31/16

Quick answer

US patent 6803375 (Non-peptide inhibition of T-lymphocyte activation and therapies related thereto) held by The Regents of the University of California expires Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 12 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/065, A61K31/16, A61K31/277, A61K31/40